drugset / Trial / NCT00004863
Paclitaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of paclitaxel and GEM 231 in treating patients who have recurrent or refractory solid tumors.
Timeline
- Start
- 1999-07
- Primary completion
- 2001-08
- Completion
- 2001-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GEM 231 | Unknown | — | — |
| Subject | Paclitaxel | Small molecule | — | Intravenous |